Crucell N.V. Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Crucell N.V.'s estimated annual revenue is currently $21.2M per year.(i)
  • Crucell N.V.'s estimated revenue per employee is $208,186

Employee Data

  • Crucell N.V. has 102 Employees.(i)
  • Crucell N.V. grew their employee count by -9% last year.

Crucell N.V.'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M30%N/AN/A
#2
N/A2043%N/AN/A
#3
$6.7M33-6%N/AN/A
#4
$34.4M222-1%N/AN/A
#5
$5.2M670%$10MN/A
#6
$2M130%N/AN/A
#7
$7.5M370%$51.6MN/A
#8
$0.3M1-50%N/AN/A
#9
$4.3M21-16%$3.3MN/A
#10
$3.6M205%N/AN/A
Add Company

What Is Crucell N.V.?

Biotechnology; Pharmaceuticals

keywords:N/A

N/A

Total Funding

102

Number of Employees

$21.2M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Crucell N.V. News

2022-04-19 - Global Tratamiento de la infección por H3N2 Mercado Análisis ...

AIMM Therapeutics BV, Aphios Corporation, Crucell NV, CSL Limited, Glide Pharmaceutical Technologies Limited, ILiAD Biotechnologies LLC,...

2022-04-17 - Influenza Virus Vaccine (H1N1) Market Size And Forecast | Butantan ...

... Biological Engineering Inc, Cantacuzino Institute Of Sera And Vaccines, Changchun Institute Of Biological Products And Crucell N.V..

2022-02-22 - Global HIV Vaccines Market Research Report to 2027 - Featuring AlphaVax, Crucell and Novartis Among Others - ResearchAndMarkets.com

Global HIV Vaccines Market Research Report to 2027 - Featuring AlphaVax, Crucell and Novartis Among Others - ResearchAndMarkets.com.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.3M102-7%$100M
#2
$13.3M102-14%$874.5M
#3
$27.4M102-8%N/A
#4
$19.4M10221%$0.1M
#5
$23.1M1029%N/A